Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

The Neuronal Basis of Predictive Coding Along the Auditory Pathway: From the Subcortical Roots to Cortical Deviance Detection
Guillermo V. Carbajal, Manuel S. Malmierca
Trends in Hearing (2018) Vol. 22
Open Access | Times Cited: 204
Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine
Pejman Sehatpour, Dan V. Iosifescu, Heloise M. De Baun, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 2, pp. 164-173
Open Access | Times Cited: 24
New Developments in the Treatment of Schizophrenia: An Expert Roundtable
Joshua T. Kantrowitz, Christoph U. Correll, Rakesh Jain, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 322-330
Open Access | Times Cited: 23
New discoveries for an old drug: a review of recent olanzapine research
Amir Mohammad Meftah, Elizabeth Deckler, Leslie Citrome, et al.
Postgraduate Medicine (2019) Vol. 132, Iss. 1, pp. 80-90
Closed Access | Times Cited: 58
Neurophysiology in psychosis: The quest for disease biomarkers
Baihan Wang, Eirini Zartaloudi, Jennifer F. Linden, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications
Clément Dondé, Joshua T. Kantrowitz, Alice Medalia, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105098-105098
Open Access | Times Cited: 20
Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension study
Joshua T. Kantrowitz, Pejman Sehatpour, Michael Avissar, et al.
Brain stimulation (2019) Vol. 12, Iss. 4, pp. 981-991
Open Access | Times Cited: 50
Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
Joshua T. Kantrowitz, Daniel C. Javitt, Robert Freedman, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1339-1345
Open Access | Times Cited: 42
Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
Joshua T. Kantrowitz
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 947-959
Closed Access | Times Cited: 39
Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape
Preetika Govil, Joshua T. Kantrowitz
CNS Drugs (2025)
Closed Access
Impaired 2.5-Hz auditory steady-state response in schizophrenia
Wenpeng Hou, Xiangqin Qin, Yanbing Xiong, et al.
Brain Research (2025) Vol. 1851, pp. 149503-149503
Closed Access
Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement
Pejman Sehatpour, Joshua T. Kantrowitz
Biological Psychiatry (2024) Vol. 97, Iss. 2, pp. 128-138
Closed Access | Times Cited: 4
Towards biologically constrained attractor models of schizophrenia
Heike Stein, João Barbosa, Albert Compte
Current Opinion in Neurobiology (2021) Vol. 70, pp. 171-181
Open Access | Times Cited: 25
D-Serine: A Cross Species Review of Safety
Amir Mohammad Meftah, Hiroshi Hasegawa, Joshua T. Kantrowitz
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 23
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
Maju Mathew Koola
Complex Psychiatry (2018) Vol. 4, Iss. 3, pp. 134-148
Open Access | Times Cited: 26
Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials
Wei Zheng, Xiao-Min Zhu, Qing-E Zhang, et al.
Schizophrenia Research (2019) Vol. 209, pp. 12-21
Closed Access | Times Cited: 25
Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study
Ragy R. Girgis, Seth C. Baker, Xiangling Mao, et al.
Psychiatry Research (2019) Vol. 275, pp. 78-85
Open Access | Times Cited: 24
Impaired Potentiation of Theta Oscillations During a Visual Cortical Plasticity Paradigm in Individuals With Schizophrenia
Holly Hamilton, Brian J. Roach, Idil Çavuş, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 20
A multivariate neuromonitoring approach to neuroplasticity-based computerized cognitive training in recent onset psychosis
Shalaila S. Haas, Linda A. Antonucci, Julian Wenzel, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 4, pp. 828-835
Open Access | Times Cited: 17
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions
Joshua T. Kantrowitz
CNS Drugs (2021) Vol. 35, Iss. 11, pp. 1153-1161
Closed Access | Times Cited: 13
Glutamate modulators for treatment of schizophrenia
Naista Zhand, David Attwood, Philip D. Harvey
Personalized Medicine in Psychiatry (2019) Vol. 15-16, pp. 1-12
Closed Access | Times Cited: 12
Why mismatch negativity continues to hold potential in probing altered brain function in schizophrenia
Juanita Todd, Dean F. Salisbury, Patricia T. Michie
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 4
Interaction between BDNF Val66Met polymorphism and mismatch negativity for working memory capacity in schizophrenia
Wenpeng Hou, Xiangqin Qin, Hang Li, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Less Things Change, the More They Remain the Same: Impaired Neural Plasticity as a Critical Target for Drug Development in Neuropsychiatry
Joshua T. Kantrowitz, Daniel C. Javitt
Advances in neurobiology (2024), pp. 801-828
Closed Access | Times Cited: 1
Assessing Trial-to-Trial Variability in Auditory ERPs in Autism and Schizophrenia
Sarah M. Haigh, Laura Van Key, Pat Brosseau, et al.
Journal of Autism and Developmental Disorders (2022) Vol. 53, Iss. 12, pp. 4856-4871
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top